News

Healthcare

Staff Reporter

, Philippines

Published:

1 year ago

203 view s

(L to R): Dr. Kaye Recto, Corporate Strategy and Development, AC Health; Ms. Ruby Chiong, Chief Finance Officer, Healthway Cancer Care Hospital; Ms. Nona Ong, Chief Operating Officer, Healthway Cancer Care Hospital; Mr. Jimmy Ysmael, President and CEO, Healthway Philippines, Inc.; Mr. Bong Consing, President & CEO, Ayala Corporation; Mr. Fernando Zobel de Ayala, Adviser to the Board, Ayala Corporation; Mr. Paolo Borromeo, President and CEO, AC Health; Engr. Art Carlos, President, Constech Management Group, Inc.; Ar. Dan Lichauco, Managing Partner, Archion Architects; Mr. RJ Recio, Corporate Strategy and Development Head, AC Health; Mr. Jay Simeon, Supply Chain and Facilities Management Head, Healthway Cancer Care Hospital; Mr. Archie Guinto, Facilities Manager, Healthway Cancer Care Hospital. /Ayala Health Corp

AC Health cancer specialty hospital expected to open in Q3 23

Philippines’ first dedicated cancer hospital is over 75% complete.

The construction of Healthway Cancer Care Hospital, owned by Ayala Corporation (AC) Health, is over 75% finished and will soon offer a range of cancer treatment services.

In a statement, AC Health said the groundbreaking of the hospital began in 2021 and will open possibly two years later (third quarter of 2023).

Healthway Cancer Care Hospital will be the first dedicated cancer hospital in the Philippines, offering screening, prognosis, treatment, and post-cancer care.

AC Health will provide 18 chemotherapy infusion units, two linear accelerators, and essential diagnostic and imaging machines.

AC Health CEO Paolo Borromeo championed the collaboration of public and private hospitals to address what’s lacking in cancer care in the country.

“I am a big believer that the private and public sectors should work hand-in-hand towards improving oncology care here in the Philippines. In no other industry is collaboration more evident than in healthcare, as we saw firsthand during the COVID-19 pandemic,” said Borromeo, in the same statement.

Follow the link for more news on

Ayala Healthcare Holdings

Also Read

Global REM sleep behaviour disorder market to reach $438.6m by 2028

SG to launch national strategy for allied health professionals

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit

Top News

Global REM sleep behaviour disorder market to reach $438.6m by 2028

It is driven the increasing integration of AI and ML in RBD detection.

Healthcare

43 minutes ago

SG to launch national strategy for allied health professionals

It will also implement a mandatory continuing professional education by 2026.

Healthcare

19 hours ago

Bladder cancer cases to hit 340,000 by 2033

Older adults aged 60 and above make up about 87% of diagnosed cases.Bladder cancer cases in eight major markets, including Japan and China, are projected to grow at an annual rate of 2.24%, rising from 280,0000 cases in 2023 to 340,000 in 2033, according to GlobalData. The US will have the highest number of diagnosed cases at approximately 100,000, whilst France will report the lowest at 20,000 for 2023.Antara Bhattacharya, an associate project manager in GlobalData’s Epidemiology team, noted that men are more affected, comprising about 78% of cases, compared to 22% for women. Older adults aged 60 and above make up nearly 87% of diagnosed cases, with younger adults aged 18 to 59 accounting for about 13%.Roughly 45% of bladder cancer cases were diagnosed in early stages, with severe cases making up only 6%. Furthermore, about 79% of cases were detected at early tumour stages, compared to 4% in more advanced stages. Bhattacharya attributed the high diagnosis rates to the increased use of cystoscopy, an invasive diagnostic procedure. However, even with early-stage diagnosis, relapse and recurrence remain common, affecting approximately 74% of cases.Bladder cancer, the ninth most common type of cancer, poses challenges due to the cost and complexity of timely detection. Bhattacharya emphasised the need for comprehensive research and improved medical strategies to enhance early detection and treatment. Ongoing epidemiological studies focusing on stages of bladder cancer with a high likelihood of recurrence can contribute to better treatment outcomes. Effective treatment of bladder cancer involves a multi-pronged approach, combining medical and surgical care, lifestyle adjustments, continuous support, as well as advanced treatments like immunotherapy, targeted therapy, participation in clinical trials, and consistent follow-up.

Healthcare

23 hours ago

Primary open-angle glaucoma cases to grow to 10 million by 2033